Effect of enteral administration of insulin on intestinal development and feeding tolerance in preterm infants: a pilot study
- USDA/ARS Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, and Texas Children's Hospital, Houston, Texas, USA
- Correspondence to:
Dr Shulman, 1100 Bates St, Houston, TX 77030, USA;
rshulman{at}bcm.tmc.edu
- Accepted 6 November 2001
Abstract
Objective: To determine in a pilot study whether enteral administration of insulin to preterm infants (26–29 weeks of gestational age) would enhance gastrointestinal development and reduce feed intolerance without adverse effects.
Design: Eight preterm infants were given 4 U/kg/day insulin enterally from 4 to 28 days of age. Lactase activity was measured at 28 days of age, while measures of feed intolerance were made throughout the hospital stay. The results were compared with those of a matched historical cohort of 80 preterm infants.
Setting: Tertiary care, university affiliated hospital.
Main outcome measures: Lactase activity and feed intolerance.
Results: No adverse effects, such as hypoglycaemia, were observed after administration of insulin. The infants who received insulin had higher lactase activity and less feed intolerance than the controls (30% shorter time to full enteral feeds; fewer gastric residuals per infant).
Conclusions: These preliminary data suggest that enteral insulin administration may be of benefit in reducing feed intolerance in preterm infants. A randomised, blinded trial is warranted.
